Literature DB >> 28090306

A case of pulmonary arterial hypertension associated with adult hemophagocytic lymphohistiocytosis.

Julius Koifman1, John Granton2, John Thenganatt2.   

Abstract

Hemophagocytic lymphohistiocytosis (HLH) is an aggressive, life-threatening syndrome of excessive immune activation. Presentation is most common among the pediatric population, and cases in adults are rare. The number of nonhematologic presentations described in relation to HLH has been growing. We present a case involving a woman who developed HLH after autologous stem cell transplantation for mantle cell lymphoma. Months later, she received a diagnosis of pulmonary arterial hypertension (PAH) while undergoing treatment for her HLH. To our knowledge, PAH associated with adult HLH has only been described in the literature once before. PAH may now be a potential differential diagnosis for patients with HLH who present with respiratory symptoms.

Entities:  

Keywords:  hemophagocytic lymphohistiocytosis; hemophagocytosis; pulmonary hypertension; stem cell transplantation

Year:  2016        PMID: 28090306      PMCID: PMC5210061          DOI: 10.1086/688490

Source DB:  PubMed          Journal:  Pulm Circ        ISSN: 2045-8932            Impact factor:   3.017


  16 in total

Review 1.  Chemotherapy-induced pulmonary hypertension: role of alkylating agents.

Authors:  Benoît Ranchoux; Sven Günther; Rozenn Quarck; Marie-Camille Chaumais; Peter Dorfmüller; Fabrice Antigny; Sébastien J Dumas; Nicolas Raymond; Edmund Lau; Laurent Savale; Xavier Jaïs; Olivier Sitbon; Gérald Simonneau; Kurt Stenmark; Sylvia Cohen-Kaminsky; Marc Humbert; David Montani; Frédéric Perros
Journal:  Am J Pathol       Date:  2014-12-11       Impact factor: 4.307

2.  Increased levels of prostaglandin D(2) suggest macrophage activation in patients with primary pulmonary hypertension.

Authors:  I M Robbins; R J Barst; L J Rubin; S P Gaine; P V Price; J D Morrow; B W Christman
Journal:  Chest       Date:  2001-11       Impact factor: 9.410

Review 3.  Pulmonary veno-occlusive disease and scleroderma associated pulmonary hypertension.

Authors:  Sindhu R Johnson; Demetris Patsios; David M Hwang; John T Granton
Journal:  J Rheumatol       Date:  2006-09-15       Impact factor: 4.666

4.  Spectrum of clinical presentations in familial hemophagocytic lymphohistiocytosis type 5 patients with mutations in STXBP2.

Authors:  Marie Meeths; Miriam Entesarian; Waleed Al-Herz; Samuel C C Chiang; Stephanie M Wood; Wafa Al-Ateeqi; Francisco Almazan; Jaap J Boelens; Henrik Hasle; Marianne Ifversen; Bendik Lund; J Merlijn van den Berg; Britt Gustafsson; Hans Hjelmqvist; Magnus Nordenskjöld; Yenan T Bryceson; Jan-Inge Henter
Journal:  Blood       Date:  2010-06-17       Impact factor: 22.113

Review 5.  The role of inflammation and autoimmunity in the pathophysiology of pulmonary arterial hypertension.

Authors:  Nada Kherbeck; Mathieu C Tamby; Guillaume Bussone; Hanadi Dib; Frederic Perros; Marc Humbert; Luc Mouthon
Journal:  Clin Rev Allergy Immunol       Date:  2013-02       Impact factor: 8.667

6.  Adult hemophagocytic lymphohistiocytosis with severe pulmonary hypertension and a novel perforin gene mutation.

Authors:  Lauren M Gerard; Katharine Xing; Ines Sherifi; John Granton; David Barth; Mohamed Abdelhaleem; Catherine Bergeron; Sheila Weitzman; Christine Cserti-Gazdewich
Journal:  Int J Hematol       Date:  2012-02-23       Impact factor: 2.490

Review 7.  Histiocytic disorders: recent insights into pathophysiology and practical guidelines.

Authors:  Alexandra Filipovich; Kenneth McClain; Alexei Grom
Journal:  Biol Blood Marrow Transplant       Date:  2009-11-22       Impact factor: 5.742

8.  Pulmonary veno-occlusive disease accompanied by microangiopathic hemolytic anemia 1 year after a second bone marrow transplantation for acute lymphoblastic leukemia.

Authors:  T Kuga; K Kohda; Y Hirayama; S Matsumoto; O Nakazawa; M Ando; A Ezoe; A Nobuoka; C Mochizuki
Journal:  Int J Hematol       Date:  1996-08       Impact factor: 2.490

Review 9.  Inflammation, growth factors, and pulmonary vascular remodeling.

Authors:  Paul M Hassoun; Luc Mouthon; Joan A Barberà; Saadia Eddahibi; Sonia C Flores; Friedrich Grimminger; Peter Lloyd Jones; Michael L Maitland; Evangelos D Michelakis; Nicholas W Morrell; John H Newman; Marlene Rabinovitch; Ralph Schermuly; Kurt R Stenmark; Norbert F Voelkel; Jason X-J Yuan; Marc Humbert
Journal:  J Am Coll Cardiol       Date:  2009-06-30       Impact factor: 24.094

10.  Pulmonary hypertension following haematopoietic stem cell transplantation for primary haemophagocytic lymphohistiocytosis.

Authors:  Ulrike Zeilhofer; Michael Ashworth; Persis Amrolia; Anupama Rao; Robert Chiesa; Paul Veys; Kanchan Rao
Journal:  Pediatr Blood Cancer       Date:  2012-11-28       Impact factor: 3.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.